Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483113 · ClinicalTrials.gov registry record
DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study
A clinical trial, sponsored by Alcon Research.
- Terminated
- Registry status
- 192
- Enrollment target
NCT06483113: Clinical Trial study, sponsored by Alcon Research.
NCT06483113 is a clinical trial that was terminated before completion, run by Alcon Research. The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06483113 was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- 192 participants
- Enrollment target
Study Summary
The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifocal) soft contact lens regulatory requirements and standards.
Primary Outcome
Distance VA will be assessed for each eye individually with study lenses in place and recorded in Snellen. This endpoint is prespecified for DAILIES TOTAL1 spherical contact lenses and DAILIES TOTAL1 for Astigmatism contact lenses.
Interventions
- DEVICE Delefilcon A spherical soft contact lenses
- DEVICE Delefilcon A toric soft contact lenses
- DEVICE Delefilcon A multifocal soft contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2024-11-26 |
| Est. Completion | 2025-02-27 |
Why NCT06483113 stopped before completion
NCT06483113 is an observational study that tracks outcomes without assigning an intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Delefilcon A spherical soft contact lenses is the first listed.
NCT06483113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06483113 about?
NCT06483113 is a clinical study titled "DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study". The purpose of this study is to continuously assess the visual performance and safety of DAILIES TOTAL1 soft contact lenses in a real world setting and broader patient base through routine clinical practices. This activity will be used to continuously support delefilcon A (sphere, toric, and multifo...
What is the current status of trial NCT06483113?
This trial is currently terminated. The enrollment target is 192 participants. The study started on 2024-11-26. Estimated completion is 2025-02-27.
What interventions are being tested in trial NCT06483113?
The interventions under investigation include: Delefilcon A spherical soft contact lenses (DEVICE), Delefilcon A toric soft contact lenses (DEVICE), Delefilcon A multifocal soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06483113?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI